NIFTY 50 Market News

Cipla Share Price Live Updates: Cipla's Daily Change and Volatility

Cipla Share Price Live Updates: Cipla's Price Drops Below Key Moving Average

Cipla Share Price Live Updates: Cipla's Stock Performance Overview

Cipla Share Price Live Updates: Cipla's Stock Return Overview

Cipla Share Price Live Updates: Cipla's Stock Closes Strongly

Cipla Q2 Results Review: ICICI Securities Remains Bullish After Inline Numbers; Check Target Price — Cipla's Q2 FY27 operating performance was in line with its expectation, although the high base of gRevlimid sales last year continued to weigh on reported performance, says the brokerage.

Cipla Share Price Live Updates: Cipla's Trading Dynamics

Cipla’s US recovery, biosimilar pipeline key to future growth prospects — Cipla's September-quarter earnings suffered due to a high base in its US business. The company reported sequential growth driven by its strong India business and branded prescription therapies. Recent approvals for respiratory products and a growing biosimilar pipeline bolster Cipla's optimism for future growth. Despite declining operating margins, the firm anticipates improvements supported by product launches. Cipla remains focused on evaluating inorganic opportunities to enhance its specia…

Cipla Eyes Margin Rebound From FY28 As Middle East Freight Squeeze Hits Q2 Costs — Cipla Ltd.'s September-quarter earnings were weighed down by lower revenue from North America and its API and other businesses, partly offset by growth in India. It aims to achieve $1 billion in revenue in North America.

Cipla Q2 net profit falls 35% to Rs 878 crore, revenue dips 2% — Cipla reported a 35% year-on-year decline in second-quarter net profit to Rs 878 crore, with revenue and EBITDA also falling amid weaker North American sales. India revenue grew 12%, while US regulatory approval and a biosimilar partnership supported its product pipeline.

Cipla Q2 Results: Profit falls 35% YoY to Rs 878 crore; revenue slips 2% — Cipla reported a 35% drop in consolidated net profit for Q2FY27, which stood at Rs 878 crore. The company also experienced a 2.4% year-on-year decline in revenue from operations, totaling Rs 7,404 crore. Additionally, a significant 26.7% decrease in EBITDA resulted in a lower margin of 18.7%. Nonetheless, Cipla's One India division demonstrated growth across various segments, while the company aims to enhance productivity and innovate its product offerings.

Cipla Q2 Results: Profit falls 35% YoY to Rs 878 crore, revenue slips 2% — Revenue from operations dropped 2.4% YoY to Rs 7,404 crore in Q2FY27

Cipla Q2 Preview: Net Profit Seen Falling 29% As US Business Faces Headwinds — Analysts estimate the pharmaceutical company's consolidated revenue to rise just 0.6% year on year.

Cipla Share Price Live Updates: Cipla's Current Trading Price

Cipla Share Price Live Updates: Cipla's Stock Movement Today